Gisah Guilgen
Instituto de Tecnologia do Paraná(BR)Instituto de Oncologia do Paraná(BR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Diverse Scientific and Economic Studies, Human auditory perception and evaluation, Global Cancer Incidence and Screening, COVID-19 and healthcare impacts
Most-Cited Works
- → Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study(2021)67 cited
- → Increased Calcification and Protein Nitration in Arteries of Chronic Kidney Disease Patients(2011)18 cited
- → Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence(2022)5 cited
- → Abstract OT2-22-02: Sequencing of anthracyclines and taxanes during neoadjuvant therapy of locally advanced HER2-negative breast cancer (NEOSAMBA Study/LACOG 0419)(2023)2 cited
- → Reviewing the Role of Aspirin in Chemoprevention of Colorectal Cancer(2015)1 cited
- → Acknowledgement to Reviewers(2011)
- → Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective(2022)
- → Impact of COVID-19 in early breast cancer management: a summary of the current evidence(2021)
- → Presenting the Brazilian physical activity during cancer treatment guidelines: adaptations and challenges in a low- and middle-income context(2026)
- → Recomendações Brasileiras de Atividade Física para Prevenir e Controlar o Câncer(2025)